• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

The efficacy and safety of direct oral anticoagulants vs. traditional anticoagulants in cirrhosis
ConclusionsDOAC use in cirrhotics may be as safe as traditional anticoagulants. Patients with cirrhosis at our center prescribed DOACs had less major bleeding events, while maintaining efficacy at preventing stroke or thrombosis.This article is protected by copyright. All rights reserved.
Source: European Journal of Haematology - December 22, 2016 Category: Hematology Authors: Justine Hum, Joseph J. Shatzel, Janice H. Jou, Thomas G. Deloughery Tags: Original Article Source Type: research

The efficacy and safety of direct oral anticoagulants vs traditional anticoagulants in cirrhosis
ConclusionsDirect oral anticoagulant use in patients with cirrhosis may be as safe as traditional anticoagulants. Patients with cirrhosis at our center prescribed DOACs had less major bleeding events, while maintaining efficacy at preventing stroke or thrombosis.
Source: European Journal of Haematology - January 14, 2017 Category: Hematology Authors: Justine Hum, Joseph J. Shatzel, Janice H. Jou, Thomas G. Deloughery Tags: ORIGINAL ARTICLE Source Type: research

Impact of Atrial Fibrillation on Platelet Gene Expression
ConclusionsPlatelets are capable to respond to the circulatory environment of NVAF by altering transcript and changing prothrombotic status. This shows platelet potential for molecular “reprogramming” possibly induced by flow disturbances of NVAF.This article is protected by copyright. All rights reserved.
Source: European Journal of Haematology - March 16, 2017 Category: Hematology Authors: Waldemar E. Wysokinski, Alfonso Tafur, Naser Ammash, Samuel J. Asirvatham, Yanhong Wu, Izabella Gosk ‐Bierska, Diane E. Grill, Joshua P. Slusser, Jozef Mruk, Robert D. McBane Tags: Original Article Source Type: research

Effect of Atrial Fibrillation Duration on Plasma von Willebrand Factor Level
ConclusionsVWF is steadily elevated throughout the course of dysrhythmia in NVAF patients treated with warfarin and in those with higher intensity of left atrium blood stasis.This article is protected by copyright. All rights reserved.
Source: European Journal of Haematology - September 27, 2017 Category: Hematology Authors: Waldemar E. Wysokinski, Kevin P. Cohoon, Ewa A. Konik, Rowlens M Melduni, Naser M. Ammash, Samuel J. Asirvatham, Robert D. McBane Tags: Original Article Source Type: research

Safety of Direct Oral Anticoagulants versus Warfarin in Patients with Chronic Liver Disease and Atrial Fibrillation
ConclusionNo significant differences in bleeding rates were noted in patients treated with warfarin and DOAC agents. Further studies evaluating DOAC agents are needed to better understand the optimal anticoagulation strategy in setting of CLD.This article is protected by copyright. All rights reserved.
Source: European Journal of Haematology - February 1, 2018 Category: Hematology Authors: Pavel Goriacko, Keith T. Veltri Tags: Original Article Source Type: research

Safety of direct oral anticoagulants vs warfarin in patients with chronic liver disease and atrial fibrillation
ConclusionNo significant differences in bleeding rates were noted in patients treated with warfarin and DOAC agents. Further studies evaluating DOAC agents are needed to better understand the optimal anticoagulation strategy in setting of CLD.
Source: European Journal of Haematology - March 13, 2018 Category: Hematology Authors: Pavel Goriacko, Keith T. Veltri Tags: ORIGINAL ARTICLE Source Type: research